Profound Medical Inc - Product Pipeline Analysis, 2022 Update

Summary

Profound Medical Inc (Profound Medical) is a medical device company that develops and markets solutions to deliver precise ablation of the prostate. Its proprietary technology, TULSA-PRO, by combining real-time magnetic resonance imaging with transurethral, therapeutic ultrasound and closed-loop thermal feedback control enables clinicians in the ablation of malignant tissues within the prostate. Profound Medical is headquartered in Mississauga, Ontario, Canada.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Profound Medical Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Profound Medical Inc Company Overview
Profound Medical Inc Company Snapshot
Profound Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
Profound Medical Inc – Pipeline Analysis Overview
Profound Medical Inc - Key Facts
Profound Medical Inc - Major Products and Services
Profound Medical Inc Pipeline Products by Development Stage
Profound Medical Inc Ongoing Clinical Trials by Trial Status
Profound Medical Inc Pipeline Products Overview
Sonalleve MR-HIFU System - Abdominal Cancers
Sonalleve MR-HIFU System - Abdominal Cancers Product Overview
Sonalleve MR-HIFU System - Breast Cancer
Sonalleve MR-HIFU System - Breast Cancer Product Overview
Sonalleve MR-HIFU System - Breast Cancer Clinical Trial
Sonalleve MR-HIFU System - Hyperthermia
Sonalleve MR-HIFU System - Hyperthermia Product Overview
Sonalleve MR-HIFU System - Neuromodulation
Sonalleve MR-HIFU System - Neuromodulation Product Overview
Sonalleve MR-HIFU System - Pain Management
Sonalleve MR-HIFU System - Pain Management Product Overview
Sonalleve MR-HIFU System - Pain Management Clinical Trial
Sonalleve MR-HIFU System - Pancreatic Cancer
Sonalleve MR-HIFU System - Pancreatic Cancer Product Overview
Tulsa-Pro System
Tulsa-Pro System Product Overview
Tulsa-Pro System Clinical Trial
Profound Medical Inc - Key Employees
Profound Medical Inc - Locations And Subsidiaries
Head Office
Recent Developments
Profound Medical Inc, Recent Developments
Aug 04, 2021: Profound Medical Announces Second Quarter 2021 Financial Results
Feb 09, 2021: Profound Medical to Release Fourth Quarter and Full Year 2020 Financial Results on March 2 – Conference Call to Follow
Feb 04, 2020: Profound Medical retires Bank debt ahead of schedule
Jan 10, 2020: RadNet to Install the TULSA-PRO System for leading-edge customizable, incision-free prostate treatment
Jan 10, 2020: Profound Medical and RadNet sign the first-ever U.S. multi-center commercial agreement for TULSA-PRO
Dec 02, 2019: Novel MRI-guided ultrasound treatment destroys prostate cancer
Nov 25, 2019: Profound Medical announces health canada approval of TULSA-PRO
Oct 28, 2019: Profound Medical announces Nasdaq listing
Aug 16, 2019: Profound Medical receives U.S. FDA 510(k) clearance for TULSA-PRO
Aug 15, 2019: Accomplished financial executive, Steve Forte, joins Profound Medical’s board
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Profound Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Profound Medical Inc Pipeline Products by Equipment Type
Table 3: Profound Medical Inc Pipeline Products by Indication
Table 4: Profound Medical Inc, Key Facts
Table 5: Profound Medical Inc, Major Products and Services
Table 6: Profound Medical Inc Number of Pipeline Products by Development Stage
Table 7: Profound Medical Inc Pipeline Products Summary by Development Stage
Table 8: Profound Medical Inc Ongoing Clinical Trials by Trial Status
Table 9: Profound Medical Inc Ongoing Clinical Trials Summary
Table 10: Sonalleve MR-HIFU System - Abdominal Cancers - Product Status
Table 11: Sonalleve MR-HIFU System - Abdominal Cancers - Product Description
Table 12: Sonalleve MR-HIFU System - Breast Cancer - Product Status
Table 13: Sonalleve MR-HIFU System - Breast Cancer - Product Description
Table 14: Sonalleve MR-HIFU System - Breast Cancer - Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast Cancer
Table 15: Sonalleve MR-HIFU System - Hyperthermia - Product Status
Table 16: Sonalleve MR-HIFU System - Hyperthermia - Product Description
Table 17: Sonalleve MR-HIFU System - Neuromodulation - Product Status
Table 18: Sonalleve MR-HIFU System - Neuromodulation - Product Description
Table 19: Sonalleve MR-HIFU System - Pain Management - Product Status
Table 20: Sonalleve MR-HIFU System - Pain Management - Product Description
Table 21: Sonalleve MR-HIFU System - Pain Management - Evaluation of Sonalleve MR-HIFU for Non-invasive Thermal Therapy of Facet-Joint Syndrome: Feasibility and Safety Clinical Study
Table 22: Sonalleve MR-HIFU System - Pancreatic Cancer - Product Status
Table 23: Sonalleve MR-HIFU System - Pancreatic Cancer - Product Description
Table 24: Tulsa-Pro System - Product Status
Table 25: Tulsa-Pro System - Product Description
Table 26: Tulsa-Pro System - A Randomized Control Trial of Focal Prostate Ablation Versus Radical Prostatectomy
Table 27: Tulsa-Pro System - Customized Ablation of the Prostate with the TULSA Procedure Against Radical Prostatectomy Treatment: A Randomized Controlled Trial for Localized Prostate Cancer (CAPTAIN)
Table 28: Tulsa-Pro System - Customized TULSA-PRO Ablation Registry
Table 29: Tulsa-Pro System - Evaluation of the TULSA-PRO MRI-guided Transurethral Ultrasound Prostate Ablation Device in Patients with Localized Prostate Cancer: A Prospective, Single-arm, Pivotal Clinical Study
Table 30: Tulsa-Pro System - Feasibility and Safety of Transurethral HIFU in Various Prostate Diseases; Particularly Prostate Cancer
Table 31: Tulsa-Pro System - Magnetic Resonance Image (MRI) Guided High Energy Ultrasound for Focal Prostate Cancer Ablation
Table 32: Tulsa-Pro System - Prospective Clinical Safety and Efficacy Study of Lesion-targeted MRI-guided Transurethral Ultrasound Ablation for Localized Prostate Cancer
Table 33: Tulsa-Pro System - Prospective Single Institutional Study Evaluating the Outcomes for Patients Undergoing Ablative Therapies in the Management of Clinically Localized Prostate Cancer in the Primary and Salvage Setting
Table 34: Profound Medical Inc, Key Employees
Table 35: Glossary
List of Figures
Figure 1: Profound Medical Inc Pipeline Products by Equipment Type
Figure 2: Profound Medical Inc Pipeline Products by Development Stage
Figure 3: Profound Medical Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings